Breaking News Headlines Today

News about Drug Prices

Stay current with all the latest and breaking news about Drug Prices, compare headlines and perspectives between news sources on stories happening today. In total, 278 stories have been published about Drug Prices which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Drug Prices News

FDA · United States

FDA to streamline approvals of generic biologic drugs

88% Center coverage: 35 sources

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. See the Story

Drug Prices · United States

Reining in Drug Prices, Ballroom Saga, Teens and Chatbots: Catch up on the Day’s Stories | News Channel 3-12

78% Center coverage: 9 sources

By Daniel Wine, CNN Welcome to 5 Things PM! After a flurry of lawsuits, Character.AI will no longer let teens talk with its chatbots. Instead of open-ended conversations, kids under 18 will be able to create stories and animations. Here’s what else you might have missed during your busy day. 5 things 1⃣ Drug prices The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drug…See the Story

Robert F. Kennedy Jr. · United States

RFK Jr., Dr. Oz to unveil push for lower drug prices

67% Right coverage: 3 sources

WASHINGTON (NewsNation) — White House health leaders Robert F. Kennedy Jr. and Dr. Mehmet Oz are expected to announce a plan to lower drug prices Wednesday. In May, President Donald Trump signed an executive order aimed at lowering the cost of prescription drugs by implementing a "most favored nation" policy that caps the prices Americans pay based on those charged in other countries. Texas AG Paxton sues Tylenol makers over alleged link to…See the Story

340B: Survival Instincts Honed and Battle-Hardened

The federal government may have shut down, but there has been no pause for the 340B drug pricing program. The more than 1,600 safety-net hospitals my association represents are preparing for some of the biggest 340B changes since the program’s inception in 1992. We also have been busy educating lawmakers who have been asking why 340B has grown over those 30-plus years. Jan. 1 will mark the start of a new year, and also a new process 340B hospita…Drug Prices · Washington Read Article

This Is the Model of the Chilean Startup that Declared War on Inflated Drug Prices

100% Right coverage: 1 sources

It is not something new the fact of the number of pharmacies in our country, as well as the cost of medicines.In that context emerged a couple of years ago, Marketcare, Chilean startup that has a simple and powerful premise: democratizing access to health. How? Lowering the prices of medicines and changing the rules of the game.The idea arose when Nicolás Molina, Tamara Gallagher and Sebastián Sánchez identified how many people postponed or aban…Drug Prices · Chile Read Article

Reining in Drug Prices, Ballroom Saga, Teens and Chatbots: Catch up on the Day’s Stories | News Channel 3-12

78% Center coverage: 9 sources

RFK Jr., Dr. Oz to unveil push for lower drug prices

67% Right coverage: 3 sources

What Impact will DTC Programs have on Generic Drug Prices? – RamaOnHealthcare

Chris O’Dell, SVP of market solutions at Turquoise Health, explains why the administration’s efforts aren’t likely to impact generics in the near future.Pharmaceutical Executive: What impact will DTC programs have on prescription drug prices?Chris O’Dell: I’m optimistic that they will have an impact in the long term. In the near term, however, what was announced [...]Drug Prices Read Article

Bausch Health leaves Medicaid and 340B programs as drugmakers face changing calculus on pricing

100% Center coverage: 1 sources

The shift comes as the industry is under pressure from the Trump administration to lower prices and is confronting other changes in the health care system.Drug Prices · United States Read Article

Novartis CEO says pharma giant has the firepower for big M&A deals: 'Can never be done'

100% Center coverage: 1 sources

Novartis "can never be done" when it comes to major acquisitions in its sector, CEO Vas Narasimhan told CNBC.Pharma · Basel See the Story

News about Drug Prices

News about Drug Prices

Covered Most By

Local News Publishers

Top Drug Prices News

FDA to streamline approvals of generic biologic drugs

Reining in Drug Prices, Ballroom Saga, Teens and Chatbots: Catch up on the Day’s Stories | News Channel 3-12

RFK Jr., Dr. Oz to unveil push for lower drug prices

340B: Survival Instincts Honed and Battle-Hardened

This Is the Model of the Chilean Startup that Declared War on Inflated Drug Prices

How Drug Price Negotiations Transform China’s Healthcare Landscape

Drug Pricing Not Main Driver of State Medicaid Spending

FDA to streamline approvals of generic biologic drugs

Reining in Drug Prices, Ballroom Saga, Teens and Chatbots: Catch up on the Day’s Stories | News Channel 3-12

RFK Jr., Dr. Oz to unveil push for lower drug prices

What Impact will DTC Programs have on Generic Drug Prices? – RamaOnHealthcare

Bausch Health leaves Medicaid and 340B programs as drugmakers face changing calculus on pricing

Novartis CEO says pharma giant has the firepower for big M&A deals: 'Can never be done'

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Drug Prices

340B: Survival Instincts Honed and Battle-Hardened

This Is the Model of the Chilean Startup that Declared War on Inflated Drug Prices

How Drug Price Negotiations Transform China’s Healthcare Landscape

Drug Pricing Not Main Driver of State Medicaid Spending

FDA to streamline approvals of generic biologic drugs

Reining in Drug Prices, Ballroom Saga, Teens and Chatbots: Catch up on the Day’s Stories | News Channel 3-12

RFK Jr., Dr. Oz to unveil push for lower drug prices

What Impact will DTC Programs have on Generic Drug Prices? – RamaOnHealthcare

Bausch Health leaves Medicaid and 340B programs as drugmakers face changing calculus on pricing

Novartis CEO says pharma giant has the firepower for big M&A deals: 'Can never be done'